FABP9 can serve as a tumor prognostic biomarker: High expression of FABP9 is significantly associated with poor prognosis in various cancers, including prostate cancer, breast cancer, and ESCC, and has potential clinical diagnostic value[162–164]. Here, FABP9 is linked to Familial prostate cancer.